Display options
Share it on

Int J Endocrinol. 2014;2014:470592. doi: 10.1155/2014/470592. Epub 2014 Mar 17.

Quality of Life and Sexual Health in the Aging of PCa Survivors.

International journal of endocrinology

Mauro Gacci, Elisabetta Baldi, Lara Tamburrino, Beatrice Detti, Lorenzo Livi, Cosimo De Nunzio, Andrea Tubaro, Stavros Gravas, Marco Carini, Sergio Serni

Affiliations

  1. Department of Urology, University of Florence, Careggi Hospital, Viale Gramsci 7, 50121 Florence, Italy.
  2. Department of Experimental and Clinical Biomedical Sciences, Section of Clinical Pathophysiology, University of Florence, Italy.
  3. Radiotherapy, University Hospital Careggi, University of Florence, Italy.
  4. Department of Urology, Sant'Andrea Hospital, University "La Sapienza", Rome, Italy.
  5. Department of Urology, University Hospital of Larissa, Larissa, Greece.

PMID: 24744780 PMCID: PMC3976934 DOI: 10.1155/2014/470592

Abstract

Prostate cancer (PCa) is the most common malignancy in elderly men. The progressive ageing of the world male population will further increase the need for tailored assessment and treatment of PCa patients. The determinant role of androgens and sexual hormones for PCa growth and progression has been established. However, several trials on androgens and PCa are recently focused on urinary continence, quality of life, and sexual function, suggesting a new point of view on the whole endocrinological aspect of PCa. During aging, metabolic syndrome, including diabetes, hypertension, dyslipidemia, and central obesity, can be associated with a chronic, low-grade inflammation of the prostate and with changes in the sex steroid pathways. These factors may affect both the carcinogenesis processes and treatment outcomes of PCa. Any treatment for PCa can have a long-lasting negative impact on quality of life and sexual health, which should be assessed by validated self-reported questionnaires. In particular, sexual health, urinary continence, and bowel function can be worsened after prostatectomy, radiotherapy, or hormone treatment, mostly in the elderly population. In the present review we summarized the current knowledge on the role of hormones, metabolic features, and primary treatments for PCa on the quality of life and sexual health of elderly Pca survivors.

References

  1. Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12465-70 - PubMed
  2. Urology. 2005 Aug;66(2):338-43 - PubMed
  3. Lancet. 2002 Jul 13;360(9327):103-6 - PubMed
  4. BMC Cancer. 2012 Nov 22;12:543 - PubMed
  5. BMC Med. 2011 May 05;9:48 - PubMed
  6. BMJ. 2009 Nov 27;339:b4817 - PubMed
  7. Eur Urol. 2012 Mar;61(3):560-70 - PubMed
  8. J Clin Oncol. 2005 Apr 20;23(12):2772-80 - PubMed
  9. Cancer Res. 2010 Feb 1;70(3):1256-64 - PubMed
  10. Urology. 2003 Oct;62(4):707-13 - PubMed
  11. Cancer. 2007 Jun 1;109(11):2239-47 - PubMed
  12. Radiother Oncol. 2012 May;103(2):244-6 - PubMed
  13. FASEB J. 2010 Mar;24(3):769-77 - PubMed
  14. Oncogene. 2010 Jun 24;29(25):3593-604 - PubMed
  15. Urology. 2006 Feb;67(2):368-72 - PubMed
  16. Med Care. 1996 Mar;34(3):220-33 - PubMed
  17. Jpn J Clin Oncol. 2006 Apr;36(4):224-30 - PubMed
  18. Endocrinology. 2003 May;144(5):1653-5 - PubMed
  19. World J Urol. 2007 Apr;25(2):143-8 - PubMed
  20. J Urol. 1993 Aug;150(2 Pt 1):379-85 - PubMed
  21. Urology. 1998 Mar;51(3):389-96 - PubMed
  22. J Physiol Pharmacol. 2009 Dec;60 Suppl 7:19-24 - PubMed
  23. Urology. 2010 Jun;75(6):1418-23 - PubMed
  24. Int J Cancer. 2005 Aug 20;116(2):291-6 - PubMed
  25. Int J Cancer. 2004 Oct 20;112(1):78-86 - PubMed
  26. Lancet Oncol. 2012 Dec;13(12):1260-70 - PubMed
  27. J Sex Med. 2011 Feb;8(2):560-6 - PubMed
  28. Int J Impot Res. 2007 Jan-Feb;19(1):69-75 - PubMed
  29. Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1497-509 - PubMed
  30. Int J Androl. 2010 Dec;33(6):784-93 - PubMed
  31. Ann Oncol. 2008 Feb;19(2):395-6 - PubMed
  32. Best Pract Res Clin Endocrinol Metab. 2013 Aug;27(4):603-16 - PubMed
  33. Semin Radiat Oncol. 2013 Jul;23(3):198-205 - PubMed
  34. Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13728-33 - PubMed
  35. J Clin Oncol. 2000 Dec 1;18(23):3904-11 - PubMed
  36. Curr Opin Urol. 2013 Jan;23(1):88-94 - PubMed
  37. Eur Urol. 2009 Aug;56(2):237-44 - PubMed
  38. J Urol. 2007 Jun;177(6):2151-6; discussion 2156 - PubMed
  39. Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):421-32 - PubMed
  40. Int Urol Nephrol. 2012 Feb;44(1):61-70 - PubMed
  41. J Urol. 2002 Jul;168(1):9-12 - PubMed
  42. Crit Rev Oncol Hematol. 2013 Sep;87(3):224-38 - PubMed
  43. J Urol. 2001 Aug;166(2):587-92 - PubMed
  44. J Sex Med. 2010 Jan;7(1 Pt 1):234-43 - PubMed
  45. J Mol Endocrinol. 2007 Feb;38(1-2):51-66 - PubMed
  46. Urology. 2010 Nov;76(5):1231-8 - PubMed
  47. Can J Urol. 2008 Aug;15(4):4174-8; discussion 4179 - PubMed
  48. J Sex Med. 2013 Feb;10 Suppl 1:53-64 - PubMed
  49. Cancer Causes Control. 2009 Sep;20(7):1181-92 - PubMed
  50. Clin Cancer Res. 2004 Nov 1;10(21):7121-6 - PubMed
  51. Cancer Res. 2008 Jun 1;68(11):4447-54 - PubMed
  52. Br J Cancer. 1996 Jun;73(11):1417-21 - PubMed
  53. BJU Int. 2007 Oct;100(4):738-43 - PubMed
  54. N Engl J Med. 2008 Mar 20;358(12):1250-61 - PubMed
  55. Expert Opin Pharmacother. 2002 Sep;3(9):1313-28 - PubMed
  56. J Clin Endocrinol Metab. 2006 Oct;91(10):3850-6 - PubMed
  57. World J Clin Oncol. 2013 Feb 10;4(1):4-13 - PubMed
  58. J Urol. 2000 Dec;164(6):1929-34 - PubMed
  59. Clin Calcium. 2013 Aug;23(8):1185-90 - PubMed
  60. Rev Urol. 2010 Fall;12(4):e157-80 - PubMed
  61. Urology. 2013 Jul;82(1):5-10 - PubMed
  62. Cancer Causes Control. 1998 Jan;9(1):3-9 - PubMed
  63. Steroids. 2012 Aug;77(10):996-1001 - PubMed
  64. Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):617-23 - PubMed
  65. Cancer Radiother. 2010 Oct;14(6-7):563-70 - PubMed
  66. N Engl J Med. 2013 Jan 31;368(5):436-45 - PubMed
  67. Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1351-6 - PubMed
  68. Clin Endocrinol (Oxf). 1994 Mar;40(3):341-9 - PubMed
  69. Dis Model Mech. 2009 May-Jun;2(5-6):231-7 - PubMed
  70. J Natl Cancer Inst. 2004 Sep 15;96(18):1358-67 - PubMed
  71. J Sex Med. 2013 Jan;10(1):245-84 - PubMed
  72. Semin Radiat Oncol. 2012 Oct;22(4):284-94 - PubMed
  73. Med Care. 1998 Jul;36(7):1002-12 - PubMed
  74. PLoS One. 2011 Apr 28;6(4):e19059 - PubMed
  75. J Exp Clin Cancer Res. 2013 Feb 13;32:9 - PubMed
  76. Cancer. 2012 Sep 15;118(18):4619-26 - PubMed
  77. J Sex Med. 2008 Apr;5(4):919-927 - PubMed
  78. BJU Int. 2013 Feb;111(2):221-32 - PubMed
  79. Eur Urol. 2009 Jan;55(1):227-34 - PubMed
  80. Urol Oncol. 2009 Nov-Dec;27(6):668-72 - PubMed
  81. Biochem Biophys Res Commun. 2003 Oct 3;309(4):937-45 - PubMed
  82. Urology. 2001 Aug;58(2 Suppl 1):94-100 - PubMed
  83. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e17-24 - PubMed
  84. Urology. 2002 Nov;60(5):869-74 - PubMed
  85. Urology. 1999 Jan;53(1):180-6 - PubMed
  86. Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):795-800 - PubMed
  87. J Am Geriatr Soc. 2006 Jan;54(1):85-90 - PubMed
  88. Health Qual Life Outcomes. 2009 Nov 13;7:94 - PubMed
  89. Cancer Res. 2007 Oct 1;67(19):9199-206 - PubMed
  90. Urology. 2000 Dec 20;56(6):899-905 - PubMed
  91. Cancer Treat Rev. 2014 Feb;40(1):31-40 - PubMed
  92. Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12182-7 - PubMed
  93. Eur Urol. 1996;29 Suppl 2:3-9 - PubMed
  94. N Engl J Med. 2013 Aug 15;369(7):603-10 - PubMed
  95. Curr Opin Lipidol. 2009 Jun;20(3):182-9 - PubMed
  96. Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1646-50 - PubMed
  97. J Natl Cancer Inst. 2003 Jul 2;95(13):981-9 - PubMed
  98. Eur J Cancer. 2009 Jul;45(10):1831-8 - PubMed
  99. Radiother Oncol. 2006 Sep;80(3):355-62 - PubMed
  100. Best Pract Res Clin Endocrinol Metab. 2008 Apr;22(2):373-88 - PubMed
  101. BJU Int. 2011 Mar;107(6):929-35 - PubMed
  102. Urology. 2009 Jul;74(1):185-90 - PubMed
  103. Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):86-91 - PubMed
  104. Cancer Res. 2005 Jun 15;65(12):5445-53 - PubMed
  105. Cancer Cell. 2010 Jun 15;17(6):535-46 - PubMed
  106. Pharmacol Ther. 2013 Dec;140(3):223-38 - PubMed
  107. Urology. 2005 Nov;66(5 Suppl):83-94 - PubMed
  108. Urol Int. 2007;79(1):13-8 - PubMed
  109. Acta Oncol. 2012 Jul;51(6):722-9 - PubMed
  110. Urology. 2008 Nov;72(5):1121-4 - PubMed
  111. Urology. 2006 Jan;67(1):125-30 - PubMed
  112. Biosci Trends. 2010 Oct;4(5):204-12 - PubMed
  113. Cancer. 2004 Nov 1;101(9):2011-9 - PubMed
  114. N Engl J Med. 2004 Oct 7;351(15):1488-90 - PubMed
  115. Prostate. 2010 Feb 1;70(2):200-5 - PubMed
  116. Curr Opin Urol. 2008 May;18(3):333-9 - PubMed
  117. Nature. 2009 Feb 12;457(7231):E1; discussion E2-3 - PubMed
  118. Urol Oncol. 2013 Oct;31(7):1054-9 - PubMed
  119. Curr Urol Rep. 2013 Jun;14(3):214-22 - PubMed
  120. Cancer J. 2009 Jan-Feb;15(1):41-4 - PubMed
  121. Cancer J. 2013 Jan-Feb;19(1):19-24 - PubMed
  122. Endocrinology. 2000 Sep;141(9):3172-82 - PubMed
  123. Prostate Cancer Prostatic Dis. 2010 Jun;13(2):168-72 - PubMed
  124. Curr Opin Urol. 2004 May;14(3):177-83 - PubMed
  125. Scand J Urol. 2014 Apr;48(2):138-45 - PubMed
  126. Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1124-9 - PubMed
  127. Lancet Oncol. 2012 Oct;13(10):983-92 - PubMed
  128. J Biol Chem. 2012 Nov 16;287(47):39954-66 - PubMed
  129. Eur J Oncol Nurs. 2012 Jul;16(3):310-4 - PubMed
  130. Qual Life Res. 1993 Oct;2(5):319-25 - PubMed
  131. Curr Opin Urol. 2013 Jan;23(1):78-87 - PubMed
  132. JAMA. 2011 Sep 21;306(11):1205-14 - PubMed
  133. Clin Cancer Res. 2011 Sep 15;17(18):5878-88 - PubMed
  134. Eur Urol. 2007 Aug;52(2):331-43 - PubMed
  135. J Urol. 1998 Aug;160(2):449-53 - PubMed
  136. Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12188-93 - PubMed
  137. Prog Urol. 2004 Dec;14(6):1177-80 - PubMed
  138. Eur Urol. 1997;31 Suppl 3:3-8 - PubMed
  139. Eur Urol. 2011 Jul;60(1):106-17 - PubMed
  140. Endocrinology. 2003 Jun;144(6):2319-24 - PubMed
  141. J Natl Cancer Inst. 2008 Feb 6;100(3):170-83 - PubMed
  142. Am J Epidemiol. 2006 Dec 1;164(11):1094-102 - PubMed
  143. J Endocrinol Invest. 2011 Mar;34(3):232-43 - PubMed
  144. Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1357-63 - PubMed
  145. Int J Radiat Oncol Biol Phys. 1999 Mar 15;43(5):1095-101 - PubMed
  146. Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):988-93 - PubMed
  147. Neurourol Urodyn. 2010 Nov;29(8):1360-4 - PubMed
  148. Eur Urol. 2007 Feb;51(2):524-33; discussion 533 - PubMed
  149. Urology. 1997 Jun;49(6):822-30 - PubMed
  150. Urology. 2005 Jun;65(6):1157-62 - PubMed
  151. Aging Male. 2012 Dec;15(4):187-97 - PubMed
  152. J Clin Oncol. 1995 May;13(5):1249-54 - PubMed
  153. World J Urol. 2012 Jun;30(3):311-8 - PubMed
  154. J Clin Oncol. 2010 Nov 1;28(31):4687-96 - PubMed
  155. Radiat Oncol. 2013 Mar 06;8:53 - PubMed
  156. Radiother Oncol. 2005 Jul;76(1):27-34 - PubMed
  157. Eur J Cancer. 2006 May;42(8):1083-92 - PubMed
  158. BJU Int. 2006 Jun;97(6):1234-41 - PubMed
  159. Eur Urol. 2012 Apr;61(4):664-75 - PubMed
  160. Endocrinology. 2007 Sep;148(9):4334-43 - PubMed
  161. Cancer Causes Control. 2010 Jan;21(1):61-8 - PubMed
  162. J Clin Invest. 2013 Jul;123(7):2948-60 - PubMed
  163. J Urol. 2006 Dec;176(6 Pt 1):2443-7 - PubMed
  164. J Sex Med. 2012 Mar;9(3):887-902 - PubMed
  165. Clin Cancer Res. 2005 Jul 1;11(13):4653-7 - PubMed
  166. Cancer Res. 2001 Oct 1;61(19):7310-7 - PubMed
  167. J Biomed Sci. 2011 Aug 23;18:63 - PubMed
  168. Clin Genitourin Cancer. 2011 Dec;9(2):73-80 - PubMed
  169. Am J Clin Nutr. 2007 Sep;86(3):s843-57 - PubMed
  170. Harefuah. 2002 Apr;141(4):379-83, 408, 407 - PubMed
  171. Am J Epidemiol. 2006 Oct 15;164(8):769-74 - PubMed

Publication Types